Thrive Wealth Management
GILD icon

Thrive Wealth Management’s Gilead Sciences GILD Stock Holding History

Thrive Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$221K Buy
+1,485
New +$208K 0.03% 238
2026
Q2 		– Sell
-1,474
Closed -$205K – 264
2026
Q1 		$205K Buy
+1,474
New +$206K 0.03% 223
2024
Q4 		– Sell
-5,206
Closed -$436K – 210
2024
Q3 		$436K Sell
5,206
-1,788
-26% -$136K 0.08% 128
2024
Q2 		$480K Buy
6,994
+1,119
+19% +$74.7K 0.09% 107
2024
Q1 		$430K Sell
5,875
-1,900
-24% -$146K 0.09% 119
2023
Q4 		$630K Buy
7,775
+594
+8% +$46.2K 0.14% 91
2023
Q3 		$538K Buy
7,181
+157
+2% +$12.1K 0.14% 93
2023
Q2 		$541K Sell
7,024
-45
-0.6% -$3.59K 0.14% 92
2023
Q1 		$587K Buy
7,069
+883
+14% +$73.1K 0.15% 84
2022
Q4 		$531K Buy
6,186
+93
+2% +$7.36K 0.15% 86
2022
Q3 		$376K Buy
6,093
+1,301
+27% +$82K 0.13% 98
2022
Q2 		$296K Buy
+4,792
New +$297K 0.1% 122
2022
Q1 		– Sell
-4,907
Closed -$356K – 159
2021
Q4 		$356K Buy
+4,907
New +$338K 0.12% 109

Other funds holding GILD

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Thrive Wealth Management's GILD Position: Q3 2026 in Review

Thrive Wealth Management opened a new position in Gilead Sciences (GILD) in Q3 2026: 1,485 shares worth $221K. The stake represents 0.03% of the portfolio and ranks #238 among its holdings. This is a return to the name: Thrive Wealth Management previously reported a position in GILD as recently as Q1 2026.

Thrive Wealth Management first reported a position in GILD in Q4 2021 and has held it in 13 quarters since. The position peaked at $630K in Q4 2023. 2,060 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Thrive Wealth Management held 1,485 shares of Gilead Sciences worth $221K as of Q3 2026.
  • Gilead Sciences was a new Thrive Wealth Management position in Q3 2026.
  • Gilead Sciences made up 0.03% of Thrive Wealth Management's portfolio in Q3 2026, its #238 holding.
  • Thrive Wealth Management first reported a position in Gilead Sciences in Q4 2021 and has held it in 13 quarters since.
  • Thrive Wealth Management's Gilead Sciences position peaked at $630K in Q4 2023.
  • 2,060 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Thrive Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.